IB22-01

Main Content

Impact of HLA-DPB1 matching on survival following unrelated donor transplantation with post transplant cyclophosphamide for adults with hematologic malignancies.

Study #: IB22-01

Study Status: Published

Presentation(s)

2024, EBMT (Poster)

Post-Transplant Cyclophosphamide improves survival in HLA-DPB1 mismatched unrelated donor allogeneic transplantation.

Citation

McCurdy SR, Solomon SR, Shaffer BC, He M, Bolon YT, Blouin AG, Keyzner A, Socola FA, Ibrahim U, Zou J, Safah H, Saba N, Gadalla S, Perales MA, Paczesny S, Marsh SGE, Petersdorf EW, Wang T, Lee SJ, Fuchs EJ.

Transplantation and Cellular Therapy. 2025, Oct 01: S2666-6367(25): S2666-6367(25):01480-0. doi: 10.1016/j.jtct.2025.09.048. Epub 2025, Oct 01. PMCID:.

PubMed

PMID: 41043776

Abstract